Table of contents


In this issue

p165 | doi:10.1038/nrd1056

Editorial: Follow the yellow brick road

p167 | doi:10.1038/nrd1057

Top

Research Highlights

Cardiovascular disease: Metabonomics reveals blocked pipes

p169 | doi:10.1038/nrd1048

RNA-targeted drugs: The Essence of correction

p170 | doi:10.1038/nrd1029

Inflammation: Targeting two for the price of one

p170 | doi:10.1038/nrd1052

Structure-based drug design: Can GPCR models work?

p171 | doi:10.1038/nrd1030

Cardiovascular disease: Another string to LXR's bow

p172 | doi:10.1038/nrd1050

Apoptosis: If I had a hammer...

p172 | doi:10.1038/nrd1053

Allergy: Eliminating E from the class

p173 | doi:10.1038/nrd1051

Cancer: Parc keeper

p174 | doi:10.1038/nrd1049

Top

News and Analysis

Patent watch

En Banc — all together now | Erythropoietin gets bloody

p174 | doi:10.1038/nrd1055

From the analyst's couch

The painful reality

p175 | doi:10.1038/nrd1038

Fresh from the Pipeline

Eplerenone

p177 | doi:10.1038/nrd1039

Top

Reviews

Article series: Case Histories

Case history

The development of COX2 inhibitors

Rod J. Flower

p179 | doi:10.1038/nrd1034

ADMET in silico modelling: towards prediction paradise?

Han van de Waterbeemd & Eric Gifford

p192 | doi:10.1038/nrd1032

Article series: Case Histories

Case history

Tamoxifen: a most unlikely pioneering medicine

V. Craig Jordan

p205 | doi:10.1038/nrd1031

Effect of pegylation on pharmaceuticals

J. Milton Harris & Robert B. Chess

p214 | doi:10.1038/nrd1033

Article series: A guide to drug discovery

A guide to drug discovery: Combinatorial compound libraries for drug discovery: an ongoing challenge

H. Mario Geysen, Frank Schoenen, David Wagner & Richard Wagner

p222 | doi:10.1038/nrd1035

Top

Perspectives

Opinion

Biotech's twentieth birthday blues

David Miska

p231 | doi:10.1038/nrd1036

Innovation

Big physics, small doses: the use of AMS and PET in human microdosing of development drugs

Graham Lappin & R. Colin Garner

p233 | doi:10.1038/nrd1037

Correction: Therapeutic antibodies for human disease at the dawn of the twenty-first century

Ole Henrik Brekke & Inger Sandlie

p240 | doi:10.1038/nrd1060

Natureview: Reviews and comment from the nature publishing group

p241 | doi:10.1038/nrd1059

Top

Careers and Recruitment

Analytical jobs for analytical minds

Simon Frantz

p243 | doi:10.1038/nrd1058

Extra navigation

Open Innovation Challenges

naturejobs

Advertisement